Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

Rasburicase is appropriate to treat hyperuricemia in this patient with tumor lysis syndrome (TLS). TLS is characterized by the massive release of uric acid, potassium, and phosphate into the blood from rapid lysis of malignant cells. It typically occurs after initiation of cytotoxic therapy for hematologic malignancies with large tumor burden (such as high-grade lymphomas) or high cell counts (such as acute lymphoblastic leukemia),
If you want to change selection, open document below and click on "Move attachment"


owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p3563


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.